New Chairman of the Board will accelerate US growth

Leuven, Belgium/Hartford, Connecticut: 23 May 2017 - LindaCare is pleased to announce the appointment of Donald L. Deyo into the new role of Chairman of the Board, with immediate effect.

Deyo is currently CEO of FemPulse, a company developing novel neuromodulation therapy for women suffering with overactive bladder. Don was previously the founding President and CEO of Medallion Therapeutics, Inc., an Alfred Mann Foundation company involved in targeted drug delivery therapies. He also founded the executive consultancy MedTech Execs, which provides strategic and operational services to medical device and pharmaceutical companies.

More info on the on LindaCare's website.


Next > Bluebee and MediSapiens announce strategic partnership

Previous > Nexstim Plc updates the timeline for its supplementary E-FIT Phase III Trial in Stroke Rehabilitation